PATENT CLAIM ANALYSIS

Application Number: 16141781
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount, activity, or expression of the target nucleic acid in a cell. In certain embodiments, hybridization results in selective modulation of the amount, activity, or expression of a target Huntingtin gene or Huntingtin transcript in a cell.

Claim (Index 43):
The compound of  claim 42 , wherein the modified oligonucleotide has the nucleobase sequence recited in SEQ ID NO: 5.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 2.02326
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14765633', '14238441', '15880758', '14395780', '13984260']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812911235949125
- 35 USC 102 Novelty (BERT): 0.5321077862213447
- Combined Prediction Score: 0.7563727898575556
- Mean Citation Score: 307.984638
- Max Citation Score: 354.03928
- Similarity Product: 241.3212464804793

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test